19920603
 Centocor to Conduct a Second Trial of Infections Drug; Stock Price Jumps   By Winslow, Ron, The Wall Street Journal,  Jun 4, 1992  Centocor Inc plans to conduct a second formal clinical trial of its Centoxin drug for septic infections in an effort to win marketing approval from the FDA. Michael Wall, a founder of the company and chairman of its executive committee, declined to say when the trial might be completed.   
